Heparin & Alkalinized Lidocaine Bladder Instillation for Interstitial Cystitis

"While Phase 2 trials don't yet have data supporting efficacy, there is evidence that Heparin & Alkalinized Lidocaine Bladder Instillation is safe. Therefore, our team gave it a score of 2."

"Currently, there are 180 ongoing studies for Heparin & Alkalinized Lidocaine Bladder Instillation in 37 countries and 615 cities. The first study was conducted in 2006 by Ash Access Technology. That initial415-patient study completed Phase 3 drug approval in 2006. In the years since, 931 similar studies have been completed"

"Unfortunately, this study is not presently enrolling patients. The clinical trial was initially posted on September 15th 2020 and has since been updated on June 17th 2022. There are presently 1483 other trials actively admitting patients with bladder pain syndrome and 180 trials for Heparin & Alkalinized Lidocaine Bladder Instillation that are seeking participants."

"There are a total of 50 Phase 3 clinical trials for Heparin & Alkalinized Lidocaine Bladder Instillation with 180 being active as of now. Although many trials are based in Duarte, California, there are 1,499 locations running studies on this topic."

"While commonly used to treat cervical syndrome, Heparin & Alkalinized Lidocaine Bladder Instillation is also effective for prophylaxis of peripheral arterial embolism, minor burns, and medical devices."

"The research project is not presently recruiting patients, as per information available on clinicaltrials.gov. The trial was initially advertised on September 15th 2020 and last updated June 17th 2022. There are 1663 other ongoing studies that are actively looking for participants."